Actrapid (Insulin) NM 100IU/ml 10ml solution

The composition and form of issue:

Solution for injection. 1 ml contains:

insulin soluble [human genetic engineering] 100 IU (3.5 mg)

1 IU corresponds to 0,035 mg of anhydrous human insulin 

excipients: zinc chloride, glycerin (glycerol) metacresol sodium hydroxide and/or hydrochloric acid (to adjust pH) water for injection 

10 ml in glass vials, sealed with rubber stopper and plastic cap in the paper cartons 1 a bottle.

Description pharmaceutical form:

Clear, colorless liquid.

Method of application and dose:

P/K, V/V. the Dose is selected individually taking into account the patient’s needs. Typically, the patient’s demand for insulin is from 0.3 to 1 IU/kg/day. The daily insulin requirement may be higher in patients with insulinrezistentnost (e.g. in puberty, and in patients with obesity) and lower in patients with residual endogenous insulin production. If patients with diabetes achieved optimal glycemic control, complications of diabetes they have, as a rule, appear later. In this regard, the aim should be to optimize metabolic control, in particular by conducting thorough monitoring of glucose levels in the blood.

Actrapid NM is a short-acting insulin and may be used in combination with insulins of prolonged action.

The drug is administered 30 minutes before a meal or snack containing carbohydrates. Actrapid NM typically enter n/a in the region of the anterior abdominal wall. If it is convenient, the injection can be made also in the femoral region, the gluteal region or the deltoid region of the shoulder. With the introduction of the drug in the region of the anterior abdominal wall is achieved a more rapid absorption than when administered in other areas. The implementation of injection in the skin fold reduces the risk of falling into muscle.

It is necessary to change the injection site within the anatomical region to prevent the development of lipodystrophy.

The/m injection are also possible, but only on prescription.

Actrapid NM it is also possible to enter/in, and such procedures can only be done by a medical professional.

Dose adjustment

If the kidney damage or liver the need for insulin is reduced.

Storage conditions:

Opened the bottle should be stored at room temperature not exceeding 25 °C for 6 weeks not recommended store in the refrigerator. The drug should be protected from heat and sunlight.